CIA
VSAT icon

Cape Investment Advisory’s Viasat VSAT Stock Holding History

Cape Investment Advisory’s Portfolio VSAT Stock Details VSAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-70
Closed -$6.29K – 1527
2026
Q2 		$6.29K Buy
+70
New +$4.63K ﹤0.01% 969

Other funds holding VSAT

ML
MILFAM LLC Stuart, Florida $145M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
ET
Equitable Trust Nashville, Tennessee $2.38B AUM 22.38% 1-Year Est. Return
MEAC
M.E. Allison & Co San Antonio, Texas $178M AUM 23.68% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Cape Investment Advisory's VSAT Position: Q3 2026 in Review

Cape Investment Advisory sold out of Viasat (VSAT) in Q3 2026, closing a stake of 70 shares — an estimated $6.29K sold.

Cape Investment Advisory first reported a position in VSAT in Q2 2026 and held it in 1 quarter. The position peaked at $6.29K in Q2 2026. 28 funds tracked by Wall St. Rank hold VSAT as of Q3 2026.

  • Cape Investment Advisory reported no remaining Viasat position as of Q3 2026 after selling out during the quarter.
  • Cape Investment Advisory sold 70 Viasat shares in Q3 2026, an estimated $6.29K.
  • Cape Investment Advisory first reported a position in Viasat in Q2 2026 and held it in 1 quarter.
  • Cape Investment Advisory's Viasat position peaked at $6.29K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held Viasat as of Q3 2026.

Based on Cape Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.